Source: CTD_human

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Alpha-synuclein is a lipid-binding protein expressed in neurons and oligodendrocytes which is increased in Parkinson's disease. 18841091

2008

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Association to PD at SNCA was replicated in the Japanese GWAS, confirming this as a major risk locus across populations. 19915575

2009

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human BAG1 is neuroprotective in in vivo and in vitro models of Parkinson's disease. 25106480

2015

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human By comparing results of a GWAS performed on individuals of European ancestry, we identified PARK16, SNCA and LRRK2 as shared risk loci for PD and BST1 and MAPT as loci showing population differences. 19915576

2009

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. 20711177

2010

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Correlation between the biochemical pathways altered by mutated parkinson-related genes and chronic exposure to manganese. 25149416

2014

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Early exposure to paraquat sensitizes dopaminergic neurons to subsequent silencing of PINK1 gene expression in mice. 22043175

2011

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Elevated expressions of heat shock protein 70 cognate 3 and ATP synthase are known to be directly involved in A53T alpha-synuclein-mediated toxicity and PD; three up-regulated proteins (muscle LIM protein at 60A, manganese-superoxide dismutase, and troponin T) and two down-regulated proteins (chaoptin and retinal degeneration A) have literature-supported associations with cellular malfunctions. 18353766

2008

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults. 21892157

2011

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human GSM-900MHz at low dose temperature-dependently downregulates α-synuclein in cultured cerebral cells independently of chaperone-mediated-autophagy. 22185909

2012

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human In humans, mutations in the alpha-synuclein gene or exposure to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produce Parkinson's disease with loss of dopaminergic neurons and depletion of nigrostriatal dopamine. alpha-Synuclein is a vertebrate-specific component of presynaptic nerve terminals that may function in modulating synaptic transmission. 12732244

2003

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. 25064009

2014

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Lewy bodies in the brains of patients with Parkinson's disease (PD) contain aggregates of alpha-synuclein (alpha-syn). 14535945

2003

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Mechanism of copper(II)-induced misfolding of Parkinson's disease protein. 22355530

2011

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Mutation A30P in the alpha-synuclein gene is a cause of familial Parkinson disease. 15099020

2004

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Mutations in the alpha-synuclein gene (A30P and A53T) are reported to cause familial Parkinson's disease (PD), but it is not known how they result in selective dopaminergic cell death. 12151787

2002

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. 21245015

2011

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Neuronal vulnerability in Parkinson's disease. 22166454

2012

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human One major advance in this field has been the discovery of several genes associated to familial PD, including alpha synuclein, parkin, LRRK2, etc., thereby providing important insight toward basic research approaches. 25631236

2015

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Overexpression of human E46K mutant α-synuclein impairs macroautophagy via inactivation of JNK1-Bcl-2 pathway. 24833599

2014

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Parkinson disease: etiology, pathogenesis and future of gene therapy. 11535288

2001

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Patients with additional copies of the alpha-synuclein gene develop PD with a severity proportional to levels of alpha-synuclein overexpression. 17131421

2007

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human Similar to recent meta- and pooled analyses, our data suggest a lower PD risk in subjects who were either homozygous or heterozygous for the SNCA REP1 259 genotype, and a higher risk in subjects who were either homozygous or heterozygous for the REP1 263 genotype, especially among subjects with an age of onset ≤68 years. 20664293

2010

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate α-synuclein and are susceptible to oxidative stress. 22110584

2011

Entrez Id: 6622
Gene Symbol: SNCA
SNCA
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.700 Biomarker CTD_human The aggregation of alpha-synuclein is believed to be a critical factor in the etiology of Parkinson's disease. alpha-Synuclein is an abundant neuronal protein of unknown function, which is enriched in the presynaptic terminals of neurons. 12885775

2003